CD1c-restricted T cells as a potential immunotherapy for leukemia
CD1c-restricted T cells as a potential immunotherapy for leukemia
|
Loading...
Lütfen bekleyiniz...
Type
Size

İlgili Videolar

CD1c-restricted T cells as a potential immunotherapy for leukemia

CD1c-restricted T cells as a potential immunotherapy for leukemia

|
An overview of immunotherapies for leukemia

An overview of immunotherapies for leukemia

|
Is WT1 a promising candidate peptide for TCR-based immunotherapies?

Is WT1 a promising candidate peptide for TCR-based immunotherapies?

|
Challenges with immunotherapy in AML: on-target, off-tumor toxicity

Challenges with immunotherapy in AML: on-target, off-tumor toxicity

|
The promise of CD123-directed immunotherapy in AML and agents of interest

The promise of CD123-directed immunotherapy in AML and agents of interest

|
Harnessing lipid-specific TCRs to target CD1c-expressing leukemia

Harnessing lipid-specific TCRs to target CD1c-expressing leukemia

|
The current role of immuno-oncology in AML and future outlooks

The current role of immuno-oncology in AML and future outlooks

|
New research areas in the treatment of AML

New research areas in the treatment of AML

|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa